This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

STERILE CORD BLOOD COLLECTION UNIT (MSC123D)

Read time: 1 mins
Marketing start date: 14 Feb 2025

Summary of product characteristics


Description

MACO BIOTECH Collection- Sterile Cord Blood Collection Unit (MSC123D) The MSC123D Sterile Cord Blood Collection Unit consists of 250 mL collection bag containing 35 mL of Anticoagulant Citrate Phosphate Dextrose Solution USP (CPD) and one 12 gauge needle with a protective shield (SECUVAM) for the used needle. Sterile, non-pyrogenic fluid path. Sterilized by steam. Rx only. This product is not made with natural rubber latex.

Indications And Usage

INDICATIONS AND USAGE MSC123D - For collection of up to 210 mL of umbilical cord blood. Use aseptic technique.

Warnings

WARNINGS Avoid contact with sharp objects. Do not irradiate collected cord blood or components. Making multiple punctures of the umbilical cord to increase collection volume may increase the risk of contamination.

Effective Time

20241220

Version

4

Spl Product Data Elements

STERILE CORD BLOOD COLLECTION UNIT (MSC123D) anticoagulant citrate phosphate dextrose SODIUM CITRATE ANHYDROUS CITRIC ACID DEXTROSE MONOHYDRATE ANHYDROUS DEXTROSE CITRIC ACID MONOHYDRATE ANHYDROUS CITRIC ACID SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE PHOSPHATE ION

Application Number

BN125552

Brand Name

STERILE CORD BLOOD COLLECTION UNIT (MSC123D)

Generic Name

anticoagulant citrate phosphate dextrose

Product Ndc

14498-005

Product Type

HUMAN PRESCRIPTION DRUG

Route

INTRAVENOUS

Package Label Principal Display Panel

PRINCIPAL DISPLAY PANEL LABELS Collection Bag Label Overwrap Label Collection Bag Label Overwrap Label

Instructions For Use

INSTRUCTIONS FOR USE Carefully Read All the Instructions Before Use Representative Product Drawing I. PREPARATION 1. Before use, verify the integrity of the collection unit (overwrap, outlet ports, tubing…). 2. Only contents inside the inner wrap are sterile and acceptable for use in a sterile field if pouch is unopened and undamaged. II. COLLECTION PROCEDURE 1. Close the clamp 3 (clamp 4 should remain open). 2. After clamping and sectioning of the umbilical cord, place the collection bag on a mixer and perform a venipuncture at lower end of the umbilical cord with needle 1. Note: Umbilical venipunctures can be done before or after the expulsion of the placenta according to your local procedures. 3. Open clamp 3. 4. Stimulate cord blood flow by massaging the cord from the top downward to increase volume of collection. 5. When collection is completed, close clamp 3. 6. Remove needle 1 and slide down SECUVAM 2 (needle protector) over needle 1. III. ADDITION OF CORD BLOOD FROM THE TUBE TO THE SAMPLING POUCH 1. Move clamp 3 at the top of the collection line close to the needle protector 2 2. Using a blood stripper, strip the tubing from the top of the tube towards the safety ring expelling the blood in the tubing into collection bag 7. 3. Repeat this operation 3 times. 4. Mix collection bag 7. 5. Close clamp 3. IV. END OF COLLECTION 1. Close clamp 4 to secure the collection above the safety ring 8. 2. Seal the tubing above the clamp 4. 3. Fill in collection volume on the collection bag label. 4. For optimal cord blood quality, maintain the cord blood at an ambient temperature (18-26°C / 64.4-78.8°F) or cold temperature (4-12°C / 39.2-53.6°F) and process within 48 hours of collection. 1,2,3 If the collection volume is less than 60 mL, the cord blood should be processed within 24 hours of collection. VI. CONTACT INFORMATION Manufactured for United States of America (U.S.A.) by Maco Productions Polonia, Sp. z o.o. ul. Szwajcarska 22, 54-405 Wroclaw, POLAND +48 71 37 60 110 For consumer information contact: Distributed by Uneklo USA, Inc., dba Macopharma USA, 3075 Breckinridge Boulevard, Suite 405, Duluth, GA 30096, USA (770) 270-6867 VII. REFERENCES 1. Pope, B., Mitsakos, K., Bilgin, A., Hokin, B. and Grant, R: Predicting overall viability of cord blood harvests. Transfusion 2012; 52:1079-1085 2. Salge-Bartels U. Huber. M, Kleiner K, Volkers P, Seitz R, Heiden M: Evaluation of Quality Parameters for Cord Blood Donations, Transfus Med Hemother 2009; 36:317-324 3. Prof. Dr.Kogler, Jose Carreras CBB, medical Center, University of Duesseldorf : General information on the institution and the production facility of the Jose Carreras Cord Blood Bank. 2014 Representative Product Drawing

How Supplied

HOW SUPPLIED MSC123D Sterile Cord Blood Collection Unit contains: 250 mL collection bag containing 35 mL CPD 1– 12 gauge needle with a protective shield (SECUVAM) for used needle Printed volume indications as visual aid to approximate the volume.

Precautions

PRECAUTIONS The kit within its aluminum outer overwrap must be stored at room temperature and protected from freezing: do not refrigerate or freeze. DO NOT use if the overwraps or bags show any signs of alteration. This is a single use sterile kit: under no circumstances should it be reused. For optimal cord blood quality it is recommended to maintain the cord blood at an ambient temperature (18-26°C / 64.4-78.8°F) or cold temperature (4-2°C / 39.2-53.6°F) and process within 48 hours of collection. 1,2,3 . If the collection volume is less than 60 mL, the cord blood should be processed within 24 hours of collection.

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.